| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $1.65B | -20.4% |
| Cost of Revenue | $913.0M | -11.5% |
| Gross Profit | $741.0M | -29.2% |
| R&D Expense | $1.08B | +21.8% |
| SG&A Expense | $70.0M | -4.1% |
| Operating Income | -$3.23B | -9672.7% |
| Interest Expense | $24.0M | — |
| Pre-tax Income | -$3.16B | — |
| Income Tax | -$73.0M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.43B | +17.7% |
| Accounts Receivable | $212.0M | -40.6% |
| Inventory | $415.0M | +6.1% |
| Current Assets | $2.17B | +5.2% |
| Total Assets | $12.58B | -19.2% |
| Current Liabilities | $333.0M | -17.4% |
| Total Liabilities | $492.0M | -24.7% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $400.0M | +1.5% |
| Capital Expenditures | $81.0M | -17.3% |
| Investing Cash Flow | -$120.0M | -22.4% |
| Financing Cash Flow | -$66.0M | +34.0% |
| Free Cash Flow | $319.0M | +7.8% |
| -269.8% |
| Net Income | -$3.09B | — |
| EPS (Basic) | -$3.82 | — |
| EPS (Diluted) | -$3.82 | — |
| Stockholders' Equity |
| $12.09B |
| -19.0% |